Specializing in diagnostic tests for skin cancer and other dermatological conditions, the company provides decision-making tools for physicians and patients. Its focus on precision medicine and growing portfolio of tests make it a key player in the diagnostics space.
2 members of Congress have disclosed 3 trades in Castle Biosciences, Inc. (CSTL), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-03-15 | Josh Gottheimer | sell | $1K – $15K |
| 2020-12-23 | Gilbert Cisneros | buy | $1K – $15K |
| 2020-12-21 | Josh Gottheimer | buy | $1K – $15K |